carnitine and deoxycytidine

carnitine has been researched along with deoxycytidine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bresters, D; Broekhuizen, AJ; Faircloth, GT; Jimeno, J; Kaaijk, P; Kaspers, GJ	1
Chen, H; Ding, D; Dong, J; He, Z; Kou, L; Liu, X; Luo, C; Sun, J; Sun, M; Wang, G; Wang, J; Yi, X; Zhang, D; Zhao, D	1

Other Studies

2 other study(ies) available for carnitine and deoxycytidine

Article	Year
In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development. Leukemia, 2003, Volume: 17, Issue:7 Topics: Antineoplastic Agents; Blood Cells; Bone Marrow; Carnitine; Case-Control Studies; Cell Survival; Child; Deoxycytidine; Depsipeptides; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Peptides, Cyclic; Podophyllotoxin	2003
Combination of l-Carnitine with Lipophilic Linkage-Donating Gemcitabine Derivatives as Intestinal Novel Organic Cation Transporter 2-Targeting Oral Prodrugs. Journal of medicinal chemistry, 2017, 03-23, Volume: 60, Issue:6 Topics: Animals; Antimetabolites, Antineoplastic; Caco-2 Cells; Carnitine; Deoxycytidine; Gemcitabine; HEK293 Cells; Humans; Mice; Molecular Docking Simulation; Organic Cation Transport Proteins; Prodrugs; Solute Carrier Family 22 Member 5; Tissue Distribution	2017

Article

Year

In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development.

Leukemia, 2003, Volume: 17, Issue:7

Topics: Antineoplastic Agents; Blood Cells; Bone Marrow; Carnitine; Case-Control Studies; Cell Survival; Child; Deoxycytidine; Depsipeptides; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Peptides, Cyclic; Podophyllotoxin

2003

Combination of l-Carnitine with Lipophilic Linkage-Donating Gemcitabine Derivatives as Intestinal Novel Organic Cation Transporter 2-Targeting Oral Prodrugs.

Journal of medicinal chemistry, 2017, 03-23, Volume: 60, Issue:6

Topics: Animals; Antimetabolites, Antineoplastic; Caco-2 Cells; Carnitine; Deoxycytidine; Gemcitabine; HEK293 Cells; Humans; Mice; Molecular Docking Simulation; Organic Cation Transport Proteins; Prodrugs; Solute Carrier Family 22 Member 5; Tissue Distribution

2017